IMS Health, Inc Shareholder Files Lawsuit

An broker in IMS Health, gluttonous added money in a planned $5.2 billion takeover led by TPG Capital, aforetime Texas Pacific Group, filed a accusation in Delaware Chancery Court in Wilmington on account of accepted investors of IMS Health, Inc. (Public, NYSE:RX), who purchased the RX shares afore November 05, 2009, alleging breaches of fiduciary assignment and added violations of accompaniment law in affiliation with an declared arbitrary takeover price.

Those who are currently an broker in shares of IMS Health, Inc. (NYSE:RX), and purchased the shares afore November 05, 2009, and / or accept added advice apropos to the investigation, should acquaintance the Shareholders Foundation, Inc. at email: mail(at)shareholdersfoundation.com or at: +1 (858) 779 - 1554.

The plaintiff alleges that “The alliance comes at a time if the company’s banal amount is undervalued but its affairs for advance and added acquirement are essentially increasing”. On November 05, 2009 IMS Health, Inc. appear that it has entered into a absolute acceding to be acquired by investment funds managed by TPG Capital and the CPP Investment Board in a transaction with a absolute amount of $5.2 billion, including the acceptance of debt. Under the proposed agreement, IMS Health, Inc shareholders will accept $22.00 banknote for anniversary allotment of IMS accepted banal (NYSE:RX ) they own. IMS Health, Inc said the acceding was absolutely accustomed by the IMS Board of Directors and that the action represents a exceptional of about 50 percent over the closing allotment amount on Friday, October 16, 2009. An IMS backer reportedly said in an e-mail that the aggregation doesn’t animadversion on awaiting litigation.

According to a antecedent analysis by a law close “the transaction appears to be unfair” to accepted investors of IMS Health, Inc. (NYSE:RX) because the “offer to acquirement IMS Health, Inc. (NYSE:RX) per allotment appears opportunistically timed to crop advantage of the accepted bread-and-butter downturn”. Shares of IMS Health, Inc (NYSE:RX) traded at $20.73 per allotment afterwards the advertisement and at about $17 per allotment the day afore the news. RX shares accomplished $22.82 per allotment in August ‘08, $25.13 per allotment in May 08, over $30 per allotment in September ’07, and about $33 per allotment in 2007. The analysis “concerns whether the IMS Health Board of Directors aperture their fiduciary duties to IMS Health, Inc. (RX) shareholders by accordant to advertise IMS Health at an arbitrary amount thereby harming IMS Health, Inc and its shareholders”, “whether the admiral of IMS Health, Inc may accept breached their fiduciary duties by not acting in RX shareholders' best interests”, and “the Company may not accept abundantly shopped itself about afore entering into this transaction and, pursuant to this transaction, TPG Capital and the CPP Investment Board may be underpaying for IMS Health, appropriately unlawfully harming IMS (RX)shareholders.” IMS Health Incorporated, amid in Norwalk, CT, appear in 2007 Total Revenue of $2.19257billion with a Net Income of $234.04million and in 2008 Total Revenue of $2.32953billion with a Net Income of $311.25million.